Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Protein Elevated in Blood Predicts Post-Concussion Symptom Severity in Professional Athletes

  • Entrepreneurs to venture capitalists: Don?t be a Scrooge

  • Pain in a dish: Researchers turn skin cells into pain sensing neurons

  • Better assessment of decision-making capacity

  • Problem gambling, personality disorders often go hand in hand

  • Gene discovered that reduces risk of stroke

  • Homosexuality may help us bond, experts say

  • Asymptomatic atherosclerosis linked to cognitive impairment

  • How environment contributes to several human diseases

  • Alzheimer's in a dish model converts skin cells to induced neurons expressing amyloid-beta and tau

  •